A Longitudinal Investigation Of The Relationships Between Patient-Reported Symptoms And Survival Among Patients with HR+/HER2- Metastatic Breast Cancer (MBC) Treated With Abemaciclib In The Phase 2 Monarch 1 Trial

We present an analysis of patient reports of these symptoms over the course of the trial, with fatigue as the central concept. We explicitly consider missing data, the relationships between symptoms, and the relationships with survival.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research